Document Detail


Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
MedLine Citation:
PMID:  32006     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Eight hypertensive patients with angina pectoris had placebo added to their existing medications for 8 weeks, then incremental doses of active labetalol with simultaneous stepwise reduction in other medicines until blood pressure was satisfactorily controlled; after that only labetalol and thiazide (8 weeks) and finally labetalol-placebo together with previous beta-adrenoreceptor antagonists and thiazide for 4 weeks were administered. 2. During the labetalol plus thiazide period resting blood pressures and measurements obtained during isotonic exercise, isometric exercise and the cold pressor test were significantly lower than during the initial placebo addition period. Angina scores were significantly reduced during this period. 3. During the final treatment with placebo, beta-adrenoreceptor antagonist and thiazide, blood pressures remained reduced, but angina was significantly worse. 4. Labetalol which antagonizes both alpha- and beta-adrenoreceptors produced better relief of angina pectoris than beta-adrenoreceptor antagonists during improvement in blood pressure in hypertensive patients.
Authors:
W F Lubbe; D A White
Related Documents :
10630826 - Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of car...
6794766 - Neonatal effects of maternal administration of acebutolol.
6145656 - Assessment of adrenergic beta-blockade in the anesthetized rat at different baseline va...
22743796 - 'long' pressure reactivity index (l-prx) as a measure of autoregulation correlates with...
2735366 - Pressure-velocity analysis of uterine muscle during spontaneous dysmenorrheic contracti...
635456 - Oesophageal peristalsis. a simple system for the recording of oesophageal peristalsis, ...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Clinical science and molecular medicine. Supplement     Volume:  4     ISSN:  0144-4107     ISO Abbreviation:  Clin Sci Mol Med Suppl     Publication Date:  1978 Dec 
Date Detail:
Created Date:  1979-03-24     Completed Date:  1979-03-24     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  7907311     Medline TA:  Clin Sci Mol Med Suppl     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  283s-286s     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / therapeutic use
Adrenergic beta-Antagonists / therapeutic use
Adult
Aged
Angina Pectoris / complications,  drug therapy*
Clinical Trials as Topic
Ethanolamines / therapeutic use*
Female
Humans
Hypertension / complications,  drug therapy*
Labetalol / therapeutic use*
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Antagonists; 0/Ethanolamines; 36894-69-6/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The interaction between prazosin and clonidine.
Next Document:  beta-Adrenoreceptor-blocking agents and lipid metabolism.